Clinical Trial Update: Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a Vorinostat-containing regimen (vorinostat, fludarabine phosphate, cyclophosphamide, and rituximab) in previously untreat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine phosphate (Fludarabine phosphate)
• Rituximab (rituximab)
• Vorinostat (vorinostat)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-02-08